
Nuvectis Pharma Investor Relations Material
Latest events

Status Update
Nuvectis Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nuvectis Pharma Inc
Access all reports
Nuvectis Pharma, Inc. is a biopharmaceutical company specializing in the development of precision medicines aimed at addressing significant unmet medical needs in oncology. The company's development pipeline includes two key clinical-stage drug candidates: NXP800 and NXP900. The company is headquartered in Fort Lee, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Nuvectis Pharma Inc


Corporate Presentation
Nuvectis Pharma Inc


Corporate Presentation
Nuvectis Pharma Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NVCT
Country
🇺🇸 United States